Form 4: Vyne Therapeutics Inc. Executive Iain Stuart Reports Share Disposal for Tax Obligations

Chief Scientific Officer Iain Stuart disposed of 6,044 shares of Vyne Therapeutics Inc. to cover tax obligations related to vesting restricted stock units.

Summary

• On March 31, 2025, Iain Stuart, Chief Scientific Officer of Vyne Therapeutics Inc., disposed of 6,044 shares of common stock.
• The shares were withheld by the issuer to satisfy tax withholding requirements related to the vesting of restricted stock units.
• The transaction price was $1.58 per share.
• Following the transaction, Stuart directly owns 122,593 shares of Vyne Therapeutics Inc.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to tax obligations, so it doesn't convey strong positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value and prospects.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.

Key Dates

Keywords

Form 4, Beneficial Ownership, Iain Stuart, VYNE Therapeutics Inc., Tax Withholding, Restricted Stock Units, Share Disposal, Officer